» Authors » Ashley E Ross

Ashley E Ross

Explore the profile of Ashley E Ross including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 235
Citations 5409
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang M, Rac G, Felice M, Ellis J, Handa N, Li E, et al.
Urol Oncol . 2025 Mar; PMID: 40082107
Objectives: To investigate whether preoperative prostate MRI findings predicted biopsy to radical prostate (RP) grade group concordance, presence of extraprostatic extension (EPE), and biochemical recurrence (BCR) after RP. Material And...
2.
Brooke A, Ojha S, Murrow D, Ross A
ACS Chem Neurosci . 2025 Feb; 16(5):772-780. PMID: 39988830
Neuroimmune communication is crucial for the body's response to physiological challenges, homeostasis, and immune stress response. Adrenergic and purinergic neurotransmission in the sympathetic nervous system is vital for this communication....
3.
Li E, Schaeffer E, Ramesh Kumar S, Zhou R, Yang X, Mana-Ay M, et al.
Eur J Nucl Med Mol Imaging . 2025 Feb; PMID: 39928105
Purpose: PSMA PET offers the potential for improved local staging prior to radical prostatectomy (RP). We evaluated PSMA PET versus mpMRI for local and nodal staging for patients with localized...
4.
Suk-Ouichai C, Huang M, Neill C, Mehta C, Ross A, Kundu S, et al.
BJUI Compass . 2025 Jan; 6(1):e460. PMID: 39877565
Objectives: The objective of this study is to evaluate preoperative factors associated with cardiopulmonary bypass (CPB) utilization and outcomes for patients with renal cell carcinoma (RCC) and tumour thrombus (TT)....
5.
Li E, Ren Y, Griffin J, Han C, Yamashita R, Mitani A, et al.
J Urol . 2025 Jan; :101097JU0000000000004435. PMID: 39841869
Purpose: Clinical variables alone have limited ability to determine which patients will have recurrence after radical prostatectomy (RP). We evaluated the ability of locked multimodal artificial intelligence (MMAI) algorithms trained...
6.
Tosoian J, Zhang Y, Meyers J, Heaton S, Siddiqui J, Xiao L, et al.
J Urol . 2025 Jan; :101097JU0000000000004421. PMID: 39836866
Purpose: The 18-gene MyProstateScore 2.0 (MPS2) test was previously validated for detection of grade group ≥ 2 (GG ≥ 2) prostate cancer using post-digital rectal examination (DRE) urine. To improve...
7.
Li E, Kumar S, Aguiar J, Siddiqui M, Sun Z, Neill C, et al.
Prostate Cancer Prostatic Dis . 2025 Jan; PMID: 39762550
Background: Traditional nomograms can inform the presence of extraprostatic extension (EPE) but not laterality, which remains important for surgical planning, and have not fully incorporated multiparametric MRI data. We evaluated...
8.
Shore N, Nielsen S, Esplin E, Antonarakis E, Barata P, Beer T, et al.
JCO Oncol Pract . 2024 Dec; OP2400626. PMID: 39700441
Indications for and implications of germline genetic testing (GGT) in patients with prostate cancer have expanded over the past decade, particularly related to precision therapies and management. GGT has become...
9.
Modi B, Caldwell K, Witt C, Weese-Myers M, Ross A
J Neurosci Methods . 2024 Nov; 413:110321. PMID: 39532187
Background: It is advantageous to be able to both control and define a metric for ischemia severity in ex vivo models to enable more precise comparisons to in vivo models...
10.
Suk-Ouichai C, Patel H, Sato K, Kundu S, Ross A, Perry Jr K
J Surg Oncol . 2024 Oct; PMID: 39470685
Background And Objectives: Partial (PN)/radical (RN) nephrectomy is the standard treatment for localized renal-cell carcinoma (RCC). The potential risks of these procedures are concerns for the elderly. We evaluated perioperative...